glp-1 issues for Weight Loss and Diabetes GLP-1RA Essentials in Gastroenterology: Side
Description
[DOI] [PubMed] [Google Scholar] 56.Batista AF, et al
Among non-users, injection aversion remains a meaningful barrier to uptake
& Roman, R
Attribution language throughout this article identifies statements as brand claims
This is a biological problem, just like high blood pressure or high blood sugar
Impact The introduction of generic semaglutide is expected to lead to significant price reductions for these widely used GLP-1 drugs, making them more accessible to a larger patient population suffering from obesity and type 2 diabetes
